References
- Zang DY, Deeg HJ. Allogeneic hematopoietic cell transplantation for patients with myelofibrosis. Curr Opin Hematol 2009;16:140–146.
- Jacobs P, Sellars S. Granulocytic sarcoma preceding leukaemic transformation in myelofibrosis. Postgrad Med J 1985;61:1069–1071.
- Chan AC, Kwong YL, Lam CC. Granulocytic sarcoma of megakaryoblastic differentiation complicating chronic idiopathic myelofibrosis. Hum Pathol 1996;27:417–420.
- Hirose Y, Masaki Y, Shimoyama K, Sugai S, Nojima T. Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years. Eur J Haematol 2001;67:194–198.
- Chan SW, Datta NN, Thomas TM, Chan KW. Intracranial chloroma in hypereosinophilic myelofibrosis. Surg Neurol 2003;59:55–57.
- Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer 1999;85:608–615.
- Kara IO, Sahin B, Paydas S, Kara B. Granulocytic sarcoma of the heart: extramedullary relapse of acute myeloblastic leukemia after allogeneic stem cell transplantation successfully treated by chemotherapy alone. Leuk Lymphoma 2005;46:1081–1084.
- Hu SW, Huang SP, Yang SF, Chai CY. Chloroma of the testis after allogeneic peripheral blood stem cell transplantation: a case report. Kaohsiung J Med Sci 2004;20:506–511.
- Pelosini M, Benedetti E, Galimberti S, et al Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 2006;37:897–898.
- Huang J, Li CY, Mesa RA, et al Risk factors for leukemic transformation in patients with primary myelofibrosis. Cancer 2008;112:2726–2732.
- Barosi G, Bergamaschi G, Marchetti M, et al JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Blood 2007;110:4030–1036.
- Mesa RA, Powell H, Lasho T, Dewald G, McClure R, Tefferi A. JAK2(V617F) and leukemic transformation in myelofibrosis with myeloid metaplasia. Leuk Res 2006;30:1457–1460.
- Wu YY, Hung HM, Chen TS, Chao TY, Ho CL. Decreased JAK2 V617F allele burden level in a myelofibrosis with myeloid metaplasia patient with leukemic transformation. Leuk Res 2008;32:1783–1786.
- Zhang SJ, Li JY, Zhang JF, et al The decrease of JAK2 V617F allele burden in leukemia transformation of an elderly patient with myelofibrosis. Leuk Res 2009;33:e116–e118.